Aspiriant Announces New Chief Investment Officer | John Allen


Aspiriant, a leading independent wealth management firm in the U.S. (, has announced the appointment of John Allen as Chief Investment Officer. Allen is primarily responsible for leading the firm’s overall Investment Strategy & Research Group. The group, comprised of 12 investment professionals, is responsible for asset allocation, portfolio construction, manager selection and risk management.